HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-fluoro-N-[4-(thiazol-2-yl)benzyl]benzenesulfonamide → N-[4-(thiazol-2-yl)benzyl]pyridin-3-ylsulfonamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-fluoro-N-[4-(thiazol-2-yl)benzyl]benzenesulfonamide | HCID 54773958 | — |
| Reactant | [Tert-butoxycarbonyl(6-hydroxymethylpyridin-2-yl)amino]acetate | HCID 86651769 | — |
| Product | N-[4-(thiazol-2-yl)benzyl]pyridin-3-ylsulfonamide | HCID 66717376 | — |
Reaction Steps
Reaction and post-treatment were carried out in the same manner as in Example 2-(a) except for using tert-butyl([tert-butoxycarbonyl(6-hydroxymethylpyridin-2-yl)amino]acetate (101 mg, 0.298 mmol) obtained in Reference Example 3-(b), and using 4-fluoro-N-[4-(thiazol-2-yl)benzyl]benzenesulfonamide (105 mg, 0.301 mmol) obtained in Reference Example 6 in place of N-[4-(thiazol-2-yl)benzyl]pyridin-3-ylsulfonamide to afford the title compound (181 mg) as a white foam. (Yield: 91%)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08648097B2 |
| Source dataset | uspto-grants-2014_02 |
| ORD ID | ord-dfcb591475524d9fbdf2b15ef61f0c88 |
| Source note | uspto-grants-2014_02 |